Google Chrome
Safari
Firefox
Edge
Press Clipping / Sep 23, 2020
Ligand Announces its Captisol Business is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
Business Wire, September 23, 2020
Search
News / Apr 12, 2021
Guy Villax wins EY Award “Entrepreneur of the Year”
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
Press Release / Feb 22, 2022
Hovione and Zerion Pharma announce a strategic partnership to market the Dispersome® technology platform
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Press Release / Mar 18, 2025
Hovione’s new campus in Seixal enters final stage of construction. Set to open in mid-2027
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Spray drying
Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.
Article / Oct 20, 2020
The Coronavirus Crisis: Challenges and Opportunities for CMOs, CDMOs and CROs
CheManager, 20 October 2020
Article / Jun 02, 2021
Cleaning Continuous Manufacturing Equipment
Pharmaceutical Technology, 2 Junho 2021
Press Clipping / Oct 27, 2025
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.